Eribulin mesylate

Timothy K. Huyck; William Gradishar; Fil Manuguid; Peter Kirkpatrick

doi:10.1038/nrd3389

Eribulin mesylate

Timothy K. Huyck, William Gradishar, Fil Manuguid, Peter Kirkpatrick

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Original language	English (US)
Pages (from-to)	173-174
Number of pages	2
Journal	Nature Reviews Drug Discovery
Volume	10
Issue number	3
DOIs	https://doi.org/10.1038/nrd3389
State	Published - Mar 2011

ASJC Scopus subject areas

Pharmacology
Drug Discovery

Access to Document

10.1038/nrd3389

Cite this

@article{9f1ee94105c84b20a6cb9806ebf176fb,

title = "Eribulin mesylate",

author = "Huyck, {Timothy K.} and William Gradishar and Fil Manuguid and Peter Kirkpatrick",

year = "2011",

month = mar,

doi = "10.1038/nrd3389",

language = "English (US)",

volume = "10",

pages = "173--174",

journal = "Nature Reviews Drug Discovery",

issn = "1474-1776",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Eribulin mesylate

AU - Huyck, Timothy K.

AU - Gradishar, William

AU - Manuguid, Fil

AU - Kirkpatrick, Peter

PY - 2011/3

Y1 - 2011/3

UR - http://www.scopus.com/inward/record.url?scp=79952175766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952175766&partnerID=8YFLogxK

U2 - 10.1038/nrd3389

DO - 10.1038/nrd3389

M3 - Article

C2 - 21358731

AN - SCOPUS:79952175766

VL - 10

SP - 173

EP - 174

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 3

ER -

Eribulin mesylate

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this